Prostate cancer study tracks immune changes during brachytherapy

NCT ID NCT07131956

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study looks at how the immune system changes in men with prostate cancer who receive brachytherapy (internal radiation). Researchers will collect blood and tissue samples before, during, and after treatment to track immune cells and DNA. The goal is to better understand the body's response to radiation, not to test a new drug. About 200 participants will be enrolled.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could reveal how brachytherapy affects the immune system, potentially guiding future combination treatments for prostate cancer.
What could go wrong
This is an observational study, not a treatment trial. It will not directly improve outcomes for participants and may not lead to any new therapies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER (DIAGNOSIS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Klinik für Strahlentherapie

    NOT_YET_RECRUITING

    Augsburg, Bavaria, 86156, Germany

  • Klinik und Poliklinik für Strahlentherapie und Radioonkologie

    NOT_YET_RECRUITING

    Munich, Bavaria, 81377, Germany

  • Strahlenklinik Erlangen

    RECRUITING

    Erlangen, Bavaria, 91054, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.